Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
30,892,429
-
Share change
-
+783,222
-
Total reported value
-
$36,760,969
-
Put/Call ratio
-
32%
-
Price per share
-
$1.19
-
Number of holders
-
67
-
Value change
-
+$1,322,192
-
Number of buys
-
24
-
Number of sells
-
34
Institutional Holders of INFINITY PHARMACEUTICALS INC - COM (INFI) as of Q3 2022
As of 30 Sep 2022,
INFINITY PHARMACEUTICALS INC - COM (INFI) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,892,429 shares.
The largest 10 holders included
BVF INC/IL, VANGUARD GROUP INC, Polar Capital Holdings Plc, BlackRock Inc., SPHERA FUNDS MANAGEMENT LTD., Strategic Wealth Advisors Group, LLC, Gratus Capital LLC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, and EAM Investors, LLC.
This page lists
67
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.